Credulity about Acupuncture Infiltrates the New England Journal of Medicine

Why This Debate Started in the First Place

The controversy traces back in large part to a 2010 NEJM review on chronic low back pain. Critics pounced because the review treated acupuncture as a reasonable option even though the underlying trials had a recurring and awkward pattern: “real” acupuncture often performed better than usual care or no treatment, but sham acupuncture also did surprisingly well. That is the kind of result that makes skeptics sit up straighter in their chairs.

The problem is simple to state and maddening to solve. If genuine acupuncture beats doing nothing, that sounds promising. But if sham acupuncture, fake acupuncture, or “not-quite-real-but-still-kinda-needle-ish” acupuncture also beats doing nothing, what exactly has been demonstrated? A specific effect of acupuncture points? A generalized response to ritual, touch, expectation, and attention? A powerful placebo context wrapped in clinical theater? Or some combination of all three?

That uncertainty is where the charge of credulity enters the room. Critics argued that prestigious medical publishing was too willing to translate ambiguous results into practical approval. In plain English: journals were acting as though the evidence had solved the mystery when it had really just rearranged the furniture.

The Real Problem: “Better Than Nothing” Is Not the Same as “Specifically Effective”

Acupuncture research has been stuck for years in a very specific scientific traffic jam. Many studies show that patients receiving acupuncture report less pain or better function than patients receiving usual care, waiting-list control, or no intervention. That sounds useful, and in a pragmatic sense it may be. But the tougher question is whether acupuncture performs meaningfully better than sham acupuncture, where the ritual is preserved but the supposed “active ingredient” is blurred or removed.

Where the evidence looks favorable

Some evidence does lean in acupuncture’s favor, especially for chronic pain conditions. Meta-analyses have found true acupuncture superior to both no-acupuncture controls and sham procedures, though even sympathetic authors have acknowledged that the difference between true and sham acupuncture is modest. That one word, modest, does a lot of heavy lifting here. It is the scientific equivalent of saying, “Yes, technically the cake is taller, but let’s not pretend it is a skyscraper.”

Government and mainstream medical sources have also summarized condition-specific evidence that is more nuanced than either true believers or hard-line skeptics usually admit. For chronic back or neck pain, osteoarthritis, and some headache disorders, the signal is often small but not nonexistent. In pain medicine, small improvements matter to some patients, particularly those trying to avoid long-term medication use or looking for non-drug options.

Where the evidence looks underwhelming

But the evidence is hardly a victory parade. Some conditions show little or no difference between acupuncture and sham. That has been reported in areas such as irritable bowel syndrome, infertility outcomes like live birth in IVF settings, and menopause-related hot flashes. In other conditions, benefits may appear on subjective symptom scales while objective measures remain stubbornly unimpressed. That is not a trivial detail. It is the detail.

AHRQ reviews have also found that for some chronic pain questions, acupuncture may improve function without showing a clear pain advantage over sham treatment. That matters because it weakens the grander claims often made in popular discussions. Once the sham control enters the chat, the story gets less mystical and more awkward.

Why Acupuncture Is So Hard to Study Without Fooling Ourselves

Drug trials have an easier time pretending to separate signal from noise. You swallow a pill. It contains a molecule or it does not. Acupuncture is trickier because the treatment is not just the needle. It is the ritual. It is the setting. It is the practitioner’s confidence. It is the patient lying still while someone treats them like their suffering deserves focused attention instead of a rushed shrug and a billing code.

Harvard’s placebo research made this especially uncomfortable for anyone hoping for a tidy answer. Sham acupuncture has been shown to create impressive subjective improvements in some settings. In the famous asthma study, patients reported feeling similarly better with sham acupuncture, placebo inhalers, and real albuterol, even though only the active bronchodilator improved an objective lung-function measure. That does not prove acupuncture is worthless. It proves that feeling better and getting physiologically better are not always the same thing.

And that is precisely why skeptics get grumpy when journals sound too confident. If a ritual reliably improves the experience of illness, that is clinically interesting. But it is not identical to proving the specific theory behind the ritual. Pain relief, reduced distress, and improved coping are valuable outcomes. They are just not a free pass for every mechanistic claim bundled with the treatment.

How Prestige Journals Can Drift Into Credulity

Prestige journals do not usually become credulous because editors suddenly forget how statistics work. The drift is subtler than that. It happens when a journal frames limited evidence as settled clinical common sense. It happens when modest effect sizes are wrapped in enthusiastic language. It happens when the distinction between “may help some patients in some contexts” and “deserves broad intellectual respect” gets smudged.

Acupuncture is especially vulnerable to this because it flatters several modern instincts at once. It looks hands-on. It sounds holistic. It offers a non-opioid narrative in a pain-treatment world understandably nervous about pharmaceuticals. It lets medicine appear humane, ancient, and high-tech all at once. In other words, acupuncture has excellent public relations.

That does not mean every positive trial is junk. It means the intervention arrives with a cultural tailwind. And when a journal like NEJM publishes a review or trial that sounds more approving than the underlying evidence warrants, critics hear not just a clinical recommendation but a broader shift in epistemic standards. A letter responding to the 2010 NEJM piece explicitly argued that the article implied a major shift in evidence-based medicine. That was not a polite little throat-clear. That was the academic version of slamming the brakes.

The Skeptics Are Not Wrong About the Risks of Overselling

There are several reasons skeptical criticism still lands.

First, the true-versus-sham difference is often small. If the specific effect of acupuncture points is tiny while the contextual and placebo-like effects are large, then a journal should say so with all the enthusiasm of someone reading a parking ticket.

Second, sham acupuncture may not be a perfectly inert control. Some researchers argue that even superficial needling or mock procedures stimulate tissues, nerves, expectation, and meaning responses. Fair enough. But that cuts both ways. If sham is not inert, then positive comparisons become harder to interpret, not easier to celebrate.

Third, supportive symptom relief can be real without validating the broader worldview often sold with acupuncture. A patient may feel better after a session. That matters. But it does not automatically confirm meridians, qi, or a unique map of invisible healing highways crisscrossing the body like an especially poetic subway system.

Fourth, opportunity cost matters. Time, money, and attention are not infinite. When weak or modest interventions are overendorsed, stronger options can be underused, delayed, or crowded out. In pain care, the better question is not “Does acupuncture ever help?” but “How does it compare with exercise, physical therapy, cognitive behavioral approaches, good sleep care, weight management, or simply a clinician who actually listens for more than 43 seconds?”

But the Believers Are Not Entirely Imagining Things, Either

A fair article cannot stop at critique, because real-world medicine is not a debate club where the best zinger wins. Some mainstream medical institutions in the United States do use acupuncture in a restrained, symptom-focused way. Cancer centers and integrative medicine programs often present it as an adjunct for pain, nausea, fatigue, hot flashes, or treatment-related discomfort, not as a cure for cancer or a replacement for evidence-based care.

That distinction matters. Memorial Sloan Kettering and Yale-affiliated supportive care discussions, for example, place acupuncture in the lane of symptom management, not miracle-making. Mayo Clinic notes that risks are generally low when acupuncture is performed by trained practitioners using sterile needles, though bruising, soreness, and rare complications remain possible. In that narrow, honest framing, acupuncture becomes less of a metaphysical revolution and more of a possibly helpful comfort measure.

And in medicine, comfort is not trivial. If a patient with chronic pain, chemotherapy-related nausea, or treatment fatigue gets meaningful relief from a low-risk adjunct, clinicians are not irrational for considering it. What would be irrational is pretending that this practical, limited use somehow settles centuries-old claims or erases the ambiguity in the literature.

The Most Honest Position Is Also the Least Flashy

Here is the position that annoys extremists on both sides: acupuncture probably does offer some patients some symptom relief in some settings, but the evidence often supports modest, context-heavy benefits rather than a dramatic, specific, theory-confirming triumph. That is less sexy than either “ancient wisdom finally vindicated” or “complete nonsense exposed,” but it fits the record better.

In other words, the harshest title may capture a real frustration even when the full story is more complicated. Credulity about acupuncture can infiltrate elite medicine when journals blur the difference between pragmatic symptom management and proof of specific efficacy. But absolutist dismissal can also miss something important: patients are not crazy when they report benefit, and clinicians are not fools for caring about symptom relief. The real sin is sloppy interpretation.

Prestige should raise the standard of language, not lower it. A top medical journal should say, clearly and repeatedly, when effects are modest, when sham controls complicate interpretation, when outcomes are subjective, when mechanisms are uncertain, and when an intervention belongs in the “adjunctive option” bucket rather than the “validated therapeutic breakthrough” bucket. That is not anti-acupuncture. That is just pro-clarity.

What Responsible Coverage of Acupuncture Should Look Like

1. Separate symptom relief from disease modification

If acupuncture helps pain or nausea, say that. Do not let readers assume it alters the underlying disease unless evidence actually shows that.

2. Distinguish no-treatment comparisons from sham comparisons

If acupuncture beats no treatment by a wide margin but only barely edges out sham, that belongs in the headline logic, not buried in paragraph 14 like a family secret.

3. Be honest about effect size

“Statistically significant” is not the same thing as “life-changing.” Journals know this. Readers deserve it in plain English.

4. Acknowledge the power of context

Expectation, empathy, ritual, touch, and time can shape outcomes. That does not make relief fake. It makes interpretation harder.

5. Keep the hype leash short

Ancient origin is not evidence. Popularity is not evidence. A fancy journal logo is definitely not evidence. A good editor should know all three before the coffee gets cold.

Experiences Around the Topic: How This Debate Feels in Real Life

One reason the acupuncture argument refuses to die is that it lives in the gap between data and human experience. On paper, the differences between true and sham acupuncture can look modest, inconsistent, or frustratingly condition-specific. In real life, that neat skepticism collides with the unmistakable experience of people who say, “I know what the charts say, but I felt better.” That is not proof, but it is part of the social reality surrounding this topic.

For many patients, the acupuncture experience begins long before a needle is placed. It starts with being heard. Chronic pain patients, in particular, often describe a medical system that can diagnose, scan, code, and prescribe, yet still leave them feeling like they are narrating their suffering into a voicemail box. Acupuncture sessions can feel radically different. The room is quieter. The appointment is longer. The practitioner may ask more questions, touch more carefully, and frame the body as something worth patient attention instead of mere management. Even before any effect is measured, the experience itself can feel therapeutic.

Clinicians experience the issue from a different angle. Many are not trying to crown acupuncture as the emperor of healing. They are trying to help people sleep, tolerate treatment, reduce distress, and avoid medication escalation. In that setting, acupuncture can function as one more tool in a symptom-management toolbox. A doctor may think, “I am not convinced by the grand theory, but if this lowers suffering and does not derail evidence-based care, I can live with it.” That is not exactly credulity. It is often pragmatism wearing sensible shoes.

Skeptics, though, experience something else entirely: rhetorical inflation. They read a paper with small effect sizes, difficult controls, subjective endpoints, and unresolved mechanism questions, then watch the conclusion stroll out wearing the confidence of a game-changing therapy. That can feel maddening. The irritation is not just about acupuncture. It is about standards. If a prestigious journal uses careful methods but loose framing, critics worry that medicine is teaching readers to confuse hopeful interpretation with rigorous inference.

Editors and health writers face their own temptation. “Acupuncture may provide modest adjunctive symptom relief in selected patients, with interpretation limited by sham-control complexity” is accurate. It is also not exactly clickbait royalty. “Acupuncture works” is cleaner, louder, and wrong in all the interesting ways. That is how credulity seeps in: not always through bad faith, but through the ordinary publishing instinct to simplify, dramatize, and resolve ambiguity before ambiguity has finished speaking.

So the lived experience around this topic is messy in a very human way. Patients may feel genuine relief. Practitioners may see enough benefit to keep offering it. Skeptics may see enough overstatement to keep objecting. And journals may keep trying to summarize an evidence base that behaves like a cat in a bathtub: slippery, dramatic, and resistant to tidy handling. That is why this debate persists. It is not only about needles. It is about what medicine counts as proof, what patients count as help, and how often those two things stubbornly refuse to line up.